Inagami T, Tamura M
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.
Am J Med Sci. 1988 Apr;295(4):400-5. doi: 10.1097/00000441-198804000-00030.
Endogenous inhibitors of Na, K-ATPase have been implicated in the pathogenesis of salt-induced hypertension. Despite an intensive search, the inhibitor(s) have long remained elusive. We have been able to purify such an inhibitor from methanol extracts of bovine adrenal glands by multiple steps of high-performance liquid chromatography (HPLC). This compound showed striking similarity to the cardiac glycoside ouabain in its dose dependency in the inhibition of Na, K-ATPase and Na-pump activity, competitive binding to the ouabain-binding site, and dependence of these effects on K+ concentration. These results indicate that vertebrate animals contain a regulator of Na, K-ATPase.
钠钾ATP酶的内源性抑制剂与盐诱导性高血压的发病机制有关。尽管进行了深入研究,但这种抑制剂长期以来一直难以捉摸。我们通过高效液相色谱(HPLC)的多个步骤,从牛肾上腺的甲醇提取物中纯化出了这样一种抑制剂。该化合物在抑制钠钾ATP酶和钠泵活性的剂量依赖性、与哇巴因结合位点的竞争性结合以及这些效应对钾离子浓度的依赖性方面,与强心苷哇巴因具有显著相似性。这些结果表明,脊椎动物体内含有一种钠钾ATP酶的调节剂。